Literature DB >> 28414282

[Pharmacometabonomics - the novel way to personalized drug therapy].

D L Maslov1, E E Balashova1, P G Lokhov1, A I Archakov1.   

Abstract

The review is devoted to pharmacometabonomics - a new branch of science focused on personalization of drug therapy through the comprehensive analysis of metabolites of patient's biological fluids. It considers the history of pharmacometabonomic, positioning to other "-omic" sciences, and system approach, realized by this science, in determination of individual therapeutic dose of the drugs and also a technical implementation of pharmacometabonomic based on direct mass spectrometry of blood plasma metabolites. Special attention is paid to a comparative analysis of pharmacometabonomics and other main approaches to personalized therapy in the clinic, such as pharmacogenetics and therapeutic drug monitoring. Finally, prospects of pharmacometabonomics applications in clinical practice were also discussed.

Entities:  

Keywords:  mass spectrometry; metabolomics; metabonomics; personalized medicine; pharmacogenomics; pharmacometabonomics; therapeutic drug monitoring

Mesh:

Substances:

Year:  2017        PMID: 28414282     DOI: 10.18097/PBMC20176302115

Source DB:  PubMed          Journal:  Biomed Khim        ISSN: 2310-6905


  2 in total

Review 1.  Metabolomics Community in Russia: History of Development, Key Participants, and Results.

Authors:  Elena E Balashova; Dmitry L Maslov; Oxana P Trifonova
Journal:  BioTech (Basel)       Date:  2020-10-25

Review 2.  Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization.

Authors:  Oxana P Trifonova; Dmitri L Maslov; Elena E Balashova; Guzel R Urazgildeeva; Denis A Abaimov; Ekaterina Yu Fedotova; Vsevolod V Poleschuk; Sergey N Illarioshkin; Petr G Lokhov
Journal:  Diagnostics (Basel)       Date:  2020-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.